Atreca Current Ratio 2011-2026 | BCEL

Annual Current Ratio Atreca

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.02	4.43	14.3	22.2	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
22.2	2.02	10.7

Quarterly Current Ratio Atreca

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.69	1.63	1.83	2.02	2.27	2.52	2.82	4.43	4.91	5.7	6.48	9.07	9.07	9.07	9.07	22.3	22.3	22.3	22.3	24.1	24.1	24.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
24.1	1.63	10.6

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
BioLineRx Ltd. BLRX	1.53	$ 2.25	1.81 %	$ 908 M	Israel
BioNTech SE BNTX	7.95	$ 91.28	0.11 %	$ 27.2 B	Germany
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Alnylam Pharmaceuticals ALNY	1.19	$ 330.34	3.6 %	$ 43.3 B	USA
CollPlant Biotechnologies Ltd. CLGN	3.57	$ 0.44	-16.64 %	$ 5.04 M	Israel
I-Mab IMAB	8.96	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Catalyst Pharmaceuticals CPRX	7.37	$ 24.98	1.17 %	$ 3.05 B	USA
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Corbus Pharmaceuticals Holdings CRBP	8.13	$ 10.14	-0.29 %	$ 135 M	USA
Cardiff Oncology CRDF	3.75	$ 1.58	-	$ 106 M	USA
Curis CRIS	1.38	$ 0.53	-3.07 %	$ 6.98 M	USA
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
Crinetics Pharmaceuticals CRNX	8.39	$ 37.7	1.26 %	$ 3.55 B	USA
CRISPR Therapeutics AG CRSP	6.6	$ 49.15	-0.73 %	$ 4.42 B	Schweiz
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Advaxis ADXS	5.93	-	-9.65 %	$ 45.9 M	USA
Anavex Life Sciences Corp. AVXL	11.6	$ 2.96	-1.0 %	$ 252 M	USA
Applied Molecular Transport AMTI	2.31	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	2.59	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
CytomX Therapeutics CTMX	2.88	$ 4.4	-3.51 %	$ 607 M	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Citius Pharmaceuticals CTXR	2.74	$ 0.86	0.67 %	$ 5.79 M	USA
Cue Biopharma CUE	2.68	$ 0.18	-1.61 %	$ 17.1 M	USA
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	2.67	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	3.34	-	10.36 %	$ 9.8 M	USA
Aquestive Therapeutics AQST	0.827	$ 4.09	-0.97 %	$ 437 M	USA
Cyclerion Therapeutics CYCN	3.45	$ 4.15	-32.52 %	$ 10.4 M	USA
Daré Bioscience DARE	1.1	$ 1.81	4.02 %	$ 20.2 M	USA
DBV Technologies S.A. DBVT	3.6	$ 20.36	-3.32 %	$ 2.84 B	France
Aravive ARAV	1.21	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	4.74	$ 8.22	2.37 %	$ 225 M	Israel
Aptose Biosciences APTO	0.269	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Denali Therapeutics DNLI	9.51	$ 19.38	-6.15 %	$ 3.19 B	USA
Dyadic International DYAI	1.14	$ 0.87	-2.8 %	$ 31.5 M	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	1.75	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	10.4	$ 31.37	1.0 %	$ 2.08 B	USA
Avenue Therapeutics ATXI	2.67	-	-52.27 %	$ 4.45 M	USA